MediMix Oncology
  • Home
  • Congresses
    • 2026
      • ESMO GI 2026
      • ASCO 2026
      • ELCC 2026
      • ENETS 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • EADO 2025
  • STiP
  • Webinars
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
Breast CancerSan Antonio 2022

Decoding Inter- and Intra-Tumor Heterogeneity in Lobular Breast Cancer Using Spatial Transcriptomics and Clustering Analysis

10 December 2022

Invasive lobular breast carcinoma (ILC) represents 5 to 15% of all invasive breast cancers. Recent studies showed the importance of tumour microenvironment (TME) heterogeneity on patient outcome. Dr. Serra, a PhD student at the Jules Bordet Institute in Brussels presented research to characterize TME spatial heterogeneity by performing clustering analysis on spatial transcriptomics (ST) data in frozen ILC tumour samples.

Tags:

poster

Share Article

No Comment! Be the first one.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • ESMO GI 2026
      • ASCO 2026
      • ELCC 2026
      • ENETS 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • EADO 2025
  • STiP
  • Webinars
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.